Latest News
Filana Therapeutics, Inc.
- Fifth Circuit Vacates Class Certification in Filana Therapeutics Securities Case
- Fifth Circuit vacates class certification in Filana Therapeutics securities case By Investing.com
- Form 8K Filana Therapeutics For: 20 October By Investing.com
- Filana Therapeutics, Inc. (FLNA) Stock Price Prediction for 2026, 2030-2040
- Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
- Filana Therapeutics (FLNA) Edges Lower: Shares at $0.80 as Traders Watch $0.76 Support - Butterfly Setup
- Filana Therapeutics CEO Barry Richard buys $278k in company stock
- Filana Therapeutics (FLNA) Slides 4.19% to $0.89, Testing Key Support Near $0.85 - Motive Wave
Headlines from the last 30 days, linking to the original publishers. See all market news →